SCHEMBL20150372

SCHEMBL20150372

Cc1nc(C)nc(-c2ccc3c4ccc(-c5nc(C)nc(C)n5)cc4n(-c4cc(C#N)ccc4-c4nc(C)nc(C)n4)c3c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.34
CYP11B1 P15538 1/20 0.34
CHEK1 O14757 1/20 0.34
PTGER4 P35408 1/20 0.33
KMT2A Q03164 3/20 0.33
GRM2 Q14416 1/20 0.32
S1PR1 P21453 1/20 0.32
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP2C19 P33261 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
CYP2D6 P10635 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 1/20 0.32
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32
HSD17B10 Q99714 1/20 0.32
EGLN2 Q96KS0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150371 0.94 PTGER4 (0.38) CYP11B2CYP11B1CHEK1PTGER4KMT2A
SCHEMBL20114562 0.94 CHEK1 (0.40) CYP11B2CYP11B1CHEK1PTGER4KMT2A
SCHEMBL20115133 0.93 L3MBTL1 (0.40) PTGER4KMT2ACYP1A2CYP3A4MEN1
SCHEMBL20114538 0.92 TDP2 (0.34) CYP11B2CYP11B1EGLN2ITKSETDB1
SCHEMBL20115142 0.92 CHEK1 (0.34) CYP11B2CYP11B1CHEK1PTGER4KMT2A
SCHEMBL20150346 0.92 CHEK1 (0.36) CYP11B2CYP11B1CHEK1PTGER4GRM2
SCHEMBL20156168 0.91 STS (0.36) CYP11B2CYP11B1CHEK1PTGER4KMT2A
SCHEMBL20114569 0.91 CLK4 (0.38) CHEK1KMT2ACYP1A2CYP3A4MEN1
SCHEMBL20114543 0.91 CHEK1 (0.36) CYP11B2CYP11B1CHEK1PTGER4KMT2A
SCHEMBL20150354 0.91 CHEK1 (0.34) CYP11B2CYP11B1CHEK1PTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 CYP11B2 1259/4885CYP11B1 1765/4885CHEK1 2795/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 CYP11B2 1259/4885CYP11B1 1765/4885CHEK1 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.